Freja Ekman is involved with simulation studies of biological systems. She earned an M.Phil. in translational biomedical research from the University of Cambridge and a B.S in chemical biology from UC Berkeley. As a graduate student in Andrew Lever's lab at Cambridge, Freja designed RNA gene therapies targeting pancreatic cancer using trans-splicing technologies. During her undergraduate research in David Schaffer's lab at UC Berkeley, Freja developed targeted gene therapies to combat neurodegeneration, as well as new, improved methods for stimulating genome editing using CRISPR-Cas9. In her free time, she enjoys long distance running and camping. Having grown up in a Scandinavian family with a severe sweet tooth, she was excited to learn about the broad range of Swedish candy stores that New York City has to offer!